CLL TIM risk model predicts infection and treatment need in newly diagnosed chronic lymphocytic leukaemia

Mobile app-based symptom monitoring helps maintain quality of life in advanced cancer

Part 1: Why test?

Part 2: How to get biopsies for testing?

Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing

Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations

Cytoreductive SBRT with ipilimumab and nivolumab in de novo mRCC shows no PFS benefit but is safe

DW-MRI reduces futile surgery in colorectal peritoneal metastases undergoing cytoreductive surgery

Customised colorectal cancer early diagnosis programme can identify advanced adenomas and early-stage cancer

SABCS 2025: Latest developments in multigene testing in early breast cancer

AI and pathology reveal higher late recurrence risk in invasive lobular breast cancer

AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab